It's tomorrow. Last chance to save your spot.
This Wednesday, October 14, @AnnetteBosworth goes live for a free, one-hour Q&A, moderated by @DominicDAgosti2 and @victoria_field_.
Swipe to see a few of the questions registrants are already asking, from autophagy on a sardine fast to protein, menopause, and GLP-1 medications.
What would you ask Dr. Boz? Register today, submit your question, and join the conversation live.
📅 Tomorrow, Wednesday, October 14
🕘 9 AM PT / 12 PM ET
💻 Free on Zoom · 60 minutes · No membership required
Can't make it live? Register anyway, and we'll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
What would you ask @AnnetteBosworth?
Join us next Wednesday, October 14, for a free, one-hour Live Q&A with @AnnetteBosworth, moderated by @DominicDAgosti2 and Victoria Field.
Nearly 90 questions have already been submitted, covering ketogenic metabolic therapy, glucose and ketone patterns, fasting, GLP-1 medications, and the real-world challenges of putting these strategies into practice.
Now it's your turn! Register, submit your question, and join the conversation live.
📅 Wednesday, October 14
🕘 9 AM PT / 12 PM ET
💻 Free on Zoom · 60 minutes · No membership required
Can't make it live? Register anyway, and we'll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
Have questions about GLP-1s and ketosis?
In this clip from The Metabolic Link, @AnnetteBosworth shares her clinical observations from patients who were already in ketosis when they started a GLP-1 at a low dose, and @DominicDAgosti2 discusses how being in ketosis could potentially influence the metabolic response.
Now it’s your turn. For one hour, Dr. Boz will take your questions live on Zoom, with Dom and Victoria Field moderating.
Bring the questions that matter to you. A few to get you thinking:
• How does ketogenic nutrition fit alongside GLP-1s, and what should be considered when reducing or discontinuing them?
• Why is my morning glucose still high, or my ketones low, despite eating very few carbs?
• How do I know when fasting is helping versus when I’m pushing it too far?
• In perimenopause or menopause, if cutting carbs isn’t working like it used to, what should I reassess?
Wednesday, October 14 · 9 AM PT / 12 PM ET
Free · Live on Zoom · 60 minutes · No membership required
Can’t make it live? Register anyway, and we’ll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
What would an emergency physician tell his patients if he could have met them 20 years before their crisis?
Dr. Michael Doney, MD, MPH, MS, spent years as a board-certified emergency physician managing the acute consequences of chronic disease. Today he is Executive Medical Director of @biograph, a preventive health clinic that combines whole-body MRI, cardiovascular imaging, DEXA, VO2 max testing, movement analysis, blood work, and genetics with a team of physicians, registered dietitians, exercise physiologists, and sleep specialists.
In this episode he walks @DominicDAgosti2 through how that data turns into a plan: why a high relative VO2 max can mask low skeletal muscle mass, especially in women in their late 40s and 50s; why Biograph talks about body recomposition, fiber, protein, and carbohydrate quality instead of weight loss alone; and what an internal study of about 1,000 members suggested about fatty liver disease in women, who in that cohort showed MASLD at lower BMI and visceral fat levels than men, with higher insulin resistance and fewer liver enzyme abnormalities. He also takes on the main critique of whole-body MRI, explaining how a standardized reporting system, subspecialty radiologists, and clinical context brought Biograph's reported referral rate for follow-up testing to about 5.4%, compared with the roughly one-third figure often cited.
The conversation also covers AI in imaging and in personal health data, diffusion-weighted MRI, a new study with Vero Bioscience tracking proteomic organ age through lifestyle interventions, mental health screening, how Biograph supports members already on GLP-1 medications, and what it would take to make this kind of prevention broadly accessible.
Viewers will come away with a clearer picture of what a comprehensive preventive assessment measures, where its limits are, and how the results translate into nutrition, exercise, and sleep interventions.
What would you ask Dr. Boz?
@AnnetteBosworth and @DominicDAgosti2 just finished recording a new episode of The Metabolic Link, and now it’s your turn to ask the questions.
For one hour, Dr. Boz will answer your questions live on Zoom, with Dom and Victoria Field moderating.
A few to get you thinking:
• Why is my morning glucose still high, or my ketones low, even when I’m eating very few carbs?
• How do I know when fasting is helping versus when I may be pushing it too far?
• How does ketogenic nutrition fit alongside GLP-1s, and what should people consider when reducing or coming off these medications?
• In perimenopause or menopause, what should I reassess if cutting carbs doesn’t seem to be working like it used to?
Wednesday, October 14 · 9 AM PT / 12 PM ET
Free · Live on Zoom · 60 minutes · No membership required
Can’t make it live? Register anyway, and we’ll email you details on how to watch the recording.
Register at live.metabolicinitiative.com.
Why are carb cravings so hard to break?
@DominicDAgosti2 explains how ketosis quiets the brain’s reward response to sugar and carbohydrates. @AnnetteBosworth, who treated addiction before she taught ketogenic diets, explains why carbs bring relief instead of joy, and why that keeps the cycle going.
In the full episode of The Metabolic Link, they also explore:
• What did Dr. Boz observe when using low-dose tirzepatide in patients already in ketosis?
• What happened to her class’s morning fasting numbers after a 72-hour sardine fast?
• Why might blood pressure medications need reassessment when starting a ketogenic diet?
• Why does she emphasize physician involvement for participants taking prescription medications?
Have a question for Dr. Boz? Join her free live Q&A on Zoom, Wednesday, October 14 at 9 AM PT / 12 PM ET. No membership required. Register at live.metabolicinitiative.com.
One person’s numbers tell one story. @AnnetteBosworth tracks 200 people at once.
In her live, 21-day online ketogenic class, participants track their glucose and ketone levels using shared dashboards that Dr. Boz monitors in real time.
Following a 72-hour sardine fast, she observed some of the class’s best morning fasting numbers the very next day.
In the full episode of The Metabolic Link, hosted by @DominicDAgosti2, they explore:
• What did Dr. Boz observe when using low-dose tirzepatide in patients already in ketosis?
• What does “relief, not joy” reveal about carbohydrate addiction?
• Why might blood pressure medications need reassessment when starting a ketogenic diet?
• Why does she emphasize physician involvement for participants taking prescription medications?
Have a question for Dr. Boz? Join her free live Q&A on Zoom, Wednesday, October 14 at 9 AM PT / 12 PM ET. No membership required. Register at live.metabolicinitiative.com
What happens when an internist teaches ketogenic nutrition to 200 students at the same time and tracks every one of their glucose and ketone readings on shared dashboards?
@AnnetteBosworth is an internal medicine physician and the author of ANYWAY YOU CAN and ketoCONTINUUM. After leaving corporate medicine she rebuilt her practice around ketone metabolic therapy, first with her own patients and now through a live 21-day class where small groups of ten work with coaches who have done the diet themselves.
In this episode she walks @DominicDAgosti2 through what that model has taught her: why every student does a 72-hour sardine fast and the changes she has observed in morning glucose and ketone readings the day after, how she started a medically supervised group already in ketosis on 0.6 mg of tirzepatide once weekly (approximately one-quarter of the labeled 2.5 mg starting dose) and her report that roughly nine in ten stayed at that dose, and why she asks every participant to keep their own physician involved as blood pressure medications may need reassessment in the first week. The conversation also covers the six-week ketogenic trial she ran with her mother during a leukemia recurrence, why she treats carbohydrate cravings the way she treated addiction in her clinic, and the free weekly support groups that classes from her first cohort still attend.
Questions Answered in This Episode:
• What has Dr. Boz observed during her 72-hour sardine challenges?
• What did Dr. Boz observe when using low-dose tirzepatide in patients already in ketosis?
• What does "relief, not joy" reveal about carbohydrate addiction?
• Why can blood pressure medications require reassessment when starting a ketogenic diet?
• Why does she emphasize physician involvement when participants take prescription medications?
• Why does she combine group coaching with glucose and ketone tracking?
Viewers will come away with a practical picture of ketone metabolic therapy as it is actually delivered: the protocol, the monitoring, the medication monitoring and reassessment, and the community structure that keeps people in it.
On Thursday, September 10, at 9 a.m. PT / 12 p.m. ET, we're hosting a special Live Q&A with Dr. Andréa Salcedo: Exploring Metabolic Gynecology: Hormones, Insulin & Women's Health, hosted by Victoria Field and Dr. Dominic D'Agostino. This one is free and open to everyone. No membership or trial required.
This isn't a lecture. It's an opportunity to join the conversation, submit your questions, and learn directly from a clinician researcher whose work examines the metabolic root causes of uterine fibroids, PCOS, and endometriosis.
Claim your free spot: membership.metabolicinitiati…
What if the uterus is an end organ, responding to insulin and inflammation the same way the heart, kidneys, and liver do?
Dr. Andréa Salcedo is a board-certified OBGYN (DO, MPH, FACOG) and associate professor at Loma Linda University School of Medicine whose research and clinical practice, which she calls conscious gynecology, examine gynecologic disease through a metabolic lens.
In this episode she walks through the evidence that uterine fibroids share progenitor cells with atherosclerotic plaque, why she now teaches residents that fibroids are cardiovascular disease of the uterus, and how high insulin acts at the level of the brain stem to block ovulation. The conversation also covers her clinical observations on fasting insulin thresholds by body type, the renaming of PCOS to PMOS, what hormonal contraceptives do and do not treat, the role of chronic stress and adversity in gynecologic disease, and the four insulin-resistant transitions of a woman's life.
Questions Answered in This Episode:
• Why are uterine fibroids being reframed as cardiovascular disease of the uterus?
• Can the menstrual cycle function as a metabolic vital sign?
• How does insulin, acting as a stress hormone, shut down ovulation?
• Is there an optimal fasting insulin for reproductive health, and does body type change the answer?
• What does the shift from PCOS to PMOS change for diagnosis and treatment?
• What happens to insulin resistance in perimenopause, and was the Women's Health Initiative misread?
Viewers will come away with a physiological framework that treats heavy periods, fibroids, irregular cycles, and PCOS as early signals of metabolic dysfunction rather than isolated hormone problems.
Join us for a free live Q&A with Dr. Salcedo here: membership.metabolicinitiati…
Today we are doing something we have never done before.
Once a month, members of The Metabolic Initiative get an hour to put their own questions directly to the scientists and clinicians at the forefront of metabolic health. Those sessions stay inside the platform. This one does not.
After Dr. Ben Bikman (@BenBikmanPhD) joined us for episode 100, the questions kept coming. So we invited him back to sit with Dr. Dominic D'Agostino (@DominicDAgosti2) and MHI co-founder Victoria Field (@victoria_field_) for a live member Q&A, and for the first time we are releasing the full session publicly.
What came out of it: GLP-1 medications and the muscle loss debate, and how Ben's own position on these drugs has shifted. Insulin resistance and ceramides. Exogenous ketones, and when they may actually be useful. Metabolic approaches to cancer and the glucose ketone index. Exercise timing. Type 1 diabetes. Cortisol and fat distribution. Supplements.
Questions Answered in This Episode:
• The muscle loss debate around GLP-1s has become polarized. Should clinicians be worried about muscle loss, muscle function, or neither?
• If you were diagnosed with cancer, are there any metabolic therapies you would start immediately?
• How long can it take for ceramides in adipose tissue to resolve — and insulin resistance to improve?
• Bioidentical D-BHB exogenous ketones are substantially more expensive. What is the value proposition over other forms?
• GLP-1 receptor agonists consistently raise resting heart rate. Is that something to be concerned about?
• Are there any emerging approaches to improving the management of type 1 diabetes?
• What happens metabolically, and to fat cells, glucose and ketones, when taking corticosteroids?
This is the kind of conversation we host every month inside The Metabolic Initiative, alongside expert presentations from our conferences and a library built entirely around metabolic health and therapy, with CME credit available on eligible content for healthcare providers.
If you want to be in the room for the next one, the first seven days are free.
Live Q&A with Dr. @BenBikmanPhD: The Future of Metabolic Health & Insulin Resistance pm Wednesday, August 19 at 9 a.m. PT / 12 p.m. ET
Join Dr. Ben Bikman, professor of cell biology and physiology at Brigham Young University and author of *Why We Get Sick*, for a special Live Q&A exploring insulin resistance, ketones, metabolic testing, GLP-1 therapies, brain energy metabolism, and the future of metabolic health.
Bring your questions. This is your opportunity to join the conversation and ask Dr. Bikman directly about the metabolic health topics that matter most to you.
He’ll be joined by Dr. @DominicDAgosti2 and MHI co-founder @victoria_field_ for an interactive discussion open to clinicians, researchers, and anyone interested in the evolving science of metabolic health.
This isn't a lecture. It's an opportunity to learn directly from one of the leading metabolism researchers whose work examines the contrasting roles of insulin and ketones in metabolic health and disease.
The session is part of The Metabolic Initiative, our CME-centered medical education platform dedicated to metabolic health and therapy. Sign up for a 7-day free trial to explore the platform, and if you become a member, you can attend this exclusive session with Dr. Bikman.
As a member, you'll also receive:
* Access to more than 250 expert-led presentations and panel discussions spanning metabolic health, cardiovascular disease, neurology, oncology, and human performance
* Live Q&As with leading researchers and clinicians
* Exclusive research reviews, eBooks, and private podcast episodes focused on metabolic health and therapy
* Opportunities to earn CME credit on eligible content for medical professionals
Members also receive access to future Live Q&As with leading researchers and clinicians.
Register for the upcoming Q&A with Dr. Ben Bikman here: membership.metabolicinitiati…
Ketogenic and low-carbohydrate diets often focus on a specific carbohydrate target: keep your net carbs under 30 grams. But as registered dietitian and certified diabetes educator @LowCarbRD demonstrates in this presentation from Metabolic Health Summit, a carbohydrate target is not a therapy. Effective implementation means a full assessment of medical history, medications, labs, food preferences, lifestyle, and the motivation that will carry a patient through year one and beyond.
Spritzler specializes in low-carbohydrate and ketogenic nutrition and has extensive experience helping people use these approaches to improve metabolic health. The creator of lowcarbdietitian.com, she walks through the practical decisions clinicians face: when a ketogenic diet is warranted versus a more flexible low-carbohydrate approach, why she recommends 1.2 to 1.8 grams of protein per kilogram rather than the RDA's 0.8, how to manage medication adjustments for patients at risk of hypoglycemia or hypotension, and how to handle electrolytes, carbohydrate counting, sweeteners, and plant-based variations without losing the patient along the way.
Questions Answered in This Episode:
• What actually separates a ketogenic diet from a low-carbohydrate diet, and when does the difference matter?
• Why is the protein RDA too low for long-term metabolic health, and what range does Spritzler recommend instead?
• Who should avoid ketogenic diets entirely, and why are most contraindications manageable with closer supervision?
• How should medications be monitored and adjusted when a patient begins carbohydrate restriction?
• Should patients count net carbs or total carbs, and why are packaged "net carb" labels unreliable?
• Can a ketogenic diet be done as a vegetarian or vegan?
A practice-tested blueprint for turning carbohydrate restriction from a prescription into a therapy patients can sustain.






